SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-052714
Filing Date
2020-04-29
Accepted
2020-04-29 06:21:39
Documents
13
Period of Report
2020-04-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8K tm2016909-1_8k.htm   iXBRL 8-K 26036
2 EXHIBIT 99.1 tm2016909d1_99-1.htm EX-99.1 152378
  Complete submission text file 0001104659-20-052714.txt   375752

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA uthr-20200429.xsd EX-101.SCH 3183
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE uthr-20200429_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE uthr-20200429_pre.xml EX-101.PRE 22708
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2016909-1_8k_htm.xml XML 3504
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26301 | Film No.: 20827197
SIC: 2834 Pharmaceutical Preparations